US$ 23.42
glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:
Description
Nat Rev Endocrinol (2023) 19:53441
![glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41569-023-00849-3/MediaObjects/41569_2023_849_Fig5_HTML.png)
However, such in-housing of third-party capacity is worrying the wider industry and could lead to further shortages going forward
![glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://diatribe.org/sites/default/files/legacy/article/screen-shot-2020-10-02-at-9_22_42-am1.png)
as BMI increases above 25, average annual health care spending among Medicare beneficiaries increases
![glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00392-025-02710-8/MediaObjects/392_2025_2710_Figa_HTML.jpg)
AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda
![glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://www.frontiersin.org/files/Articles/856111/xml-images/fphar-13-856111-g001.webp)
Puede ayudar en enfermedades cardacas, y existe la posibilidad de que tenga un efecto ms directo en las vas respiratorias
![glp-1 heart attack Cardiovascular disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10741-024-10450-6/MediaObjects/10741_2024_10450_Fig1_HTML.png)